LinkedIn is one of the fastest growing professional social networks. According to statista LinkedIn today has 433 million users.
LinkedIn distinguishes itself, from the other social media channels as being a social network that brings professionals together. Historically, this is where recruiters go to find and recruit talent and where individuals can connect for business purposes. However, today it is becoming more and more a mainstream channel to promote your brand and company messages.
1) Ok so we all know by now that LinkedIn is well known for recruiting talent. How do the pharmaceutical and healthcare sectors rank on representation when compared to other industry sectors in attracting talent?
By looking at the chart, I guess we could say pharmaceutical along with healthcare are one of the least represented industries among top attractors on LinkedIn. A sought after employer not only brings a competitive edge for the company, but also value and good reputation.
2)So what can pharmaceutical companies gain by becoming more active on LinkedIn?
First, it is probably the “safest” social media channel. If you want to start in social media, start with LinkedIn. Since the network is built on professional network, many of the comments and material or content shared tends to “stay” professional. In stark contrast to content shared in other social media channels such as FaceBook and Twitter.
Second, many modern day CEOs today are on at least one social media channel. So if a Fortune 500 CEO has to start on a social media channel, LinkedIn would be the place to get your feet wet. Ian Read Pfizer CEO was among the early pharmaceutical CEOs to join LinkedIn influencer program when it broadened its’ program.
3)What other features does LinkedIn provide?
Besides building reputation and getting your feet wet. LinkedIn launched its InMail service in February 2015 as part of its’ Marketing Solutions portfolio. Features of InMail include 1) real time dynamic delivery of sponsored emails / updates / campaigns to a target audience; 2) mobile-optimized templates making it easier to view on any mobile device, 3) rich targeting capabilities ( industry, job function for example). These all become part or should be a part of marketing strategy. LinkedIn also is a way of by bypassing open comment possibilities. This is where the safer concept comes in play.
4)Pharma LinkedIn Influencers?
The LinkedIn Influencer program launched in February 2014. This may explain why we see a more diverse set of influencers, beyond, Barak Obama and Bill Gates. Some Healthcare & Pharmaceutical CEOs that are part of the Influencer program include
Pfizer Ian Read (120,370 followers)(accessed July 28, 2016)
Abbott Laboratories Miles White (113,524 followers) (accessed July 28, 2016)
Cardinal Health George Barrett (15,823 followers) (accessed July 28, 2016)
According to social CEO report 2015 “Highly regarded companies are more than three times as likely as those with weak reputations to have a CEO who participates in social media.”
Younger CEOs are on more social media channels and they understand the benefits they can achieve from social media engagement. The advantages of being part of the influencer program allows a CEO to be able to think like a business leader, which the professional community looks up to. Pharmaceutical industry needs to learn that it must define itself externally above and beyond the brands and this is where the Influencer program can play a pivotal role. An Influencer can also help the audience understand the pharmaceutical process of bringing meds to market. CEOs engaged in social media channels can contribute to the companies ROI by bringing in reputation rewards.
5)How about leveraging all your employees?
Pharmaceutical companies can leverage one of their greatest asset, its’ employees, colleagues and associates. This is one of fastest and easiest way of broadening and reaching a greater network with your company message.
As we can see from the chart above the bigger the company the wider the reach to build up your followers.Comments closed